Supernus Pharmaceuticals Inc (SUPN) — Capital Reinvestment Ratio
Supernus Pharmaceuticals Inc (SUPN) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow ($19.86 Million) in capital expenditures ($427.00K). See Supernus Pharmaceuticals Inc (SUPN) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Supernus Pharmaceuticals Inc Capital Reinvestment Ratio (2009–2025)
This chart tracks Supernus Pharmaceuticals Inc's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Supernus Pharmaceuticals Inc (2009–2025)
Year-by-year Capital Reinvestment Ratio for Supernus Pharmaceuticals Inc from 2009 to 2025. For live market cap and broader valuation context, see Supernus Pharmaceuticals Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | $47.33 Million | $1.34 Million | ▲ +570.5% |
| 2024 | 0.00x | $171.95 Million | $725.00K | ▼ -15.0% |
| 2023 | 0.00x | $111.08 Million | $551.00K | ▲ +40.6% |
| 2022 | 0.00x | $116.83 Million | $412.00K | ▼ -78.1% |
| 2021 | 0.02x | $127.13 Million | $2.04 Million | ▼ -35.5% |
| 2020 | 0.02x | $138.40 Million | $3.45 Million | ▲ +30.4% |
| 2019 | 0.02x | $143.13 Million | $2.74 Million | ▲ +192.1% |
| 2018 | 0.01x | $128.99 Million | $844.00K | ▼ -63.0% |
| 2017 | 0.02x | $114.64 Million | $2.03 Million | ▼ -26.2% |
| 2016 | 0.02x | $66.81 Million | $1.60 Million | ▼ -63.4% |
| 2015 | 0.07x | $32.12 Million | $2.10 Million | ▼ -14.6% |
| 2014 | 0.08x | $7.73 Million | $593.00K | ▼ -71.7% |
| 2009 | 0.27x | $2.63 Million | $714.00K | — |